Diabetes Drugs Get Neither Restrictions Nor Endorsements From FDA Committee Reply

Two diabetes drugs survived a meeting of the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Tuesday. Rejecting recommendations from critics that the drugs should either be withdrawn or get new restrictions on use, the committee voted against any harsh measures, recommending only that information from two neutral clinical  trials with the drugs be added to the drugs’ labels.

The two trials were the first large large cardiovascular outcomes trials of any diabetes drugs. SAVOR-TIMI 53 studied saxagliptin (Onglyza, AstraZeneca) and EXAMINE studied alogliptin (Nesina, Takeda Pharmaceuticals).

Click here to read the full post on Forbes.

 

Advertisements

No, The Mediterranean Diet Won’t Help You Live Forever Reply

A new study published today provides fresh evidence for the healthful effects of the Mediterranean Diet. It even suggests that people who follow the Mediterranean Diet may live longer than people on most other diets. And this is just the latest piece of good news about this diet to appear in the last few years. But I want to warn my readers not to go overboard with this study. It appears to be an excellent, well-performed study, but it has many inherent limitations and is by no means definitive. In the long run it may raise as many questions as it answers.

The new study, published in The BMJfinds that women who more closely followed a Mediterranean diet had longer telomeres on the end of their chromosomes…

Click here to read the full post on Forbes.